| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.24 | 7e-12 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.18 | 8e-08 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.19 | 1e-07 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.17 | 3e-07 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.17 | 5e-07 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.16 | 3e-06 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 0.14 | 9e-06 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.21 | 7e-05 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.14 | 8e-05 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.15 | 9e-05 |